Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication

Details for Australian Patent Application No. 2004298457 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Doublet, Frederic Marc Maurice; Andries, Koenraad Jozef Lodewijk; Gevers, Tom Valerius Josepha; Meyer, Christophe; Muller, Philippe; Bonfanti, Jean-Francois; Fortin, Jerome Michel Claude; Willebrords, Rudy Edmond; Timmerman, Philip Maria Martha Bern

Agent Shelston IP

Pub. Number AU-B-2004298457

PCT Pub. Number WO2005/058869

Priority 60/566,834 30.04.04 US; 03104797.0 18.12.03 EP

Filing date 20 December 2004

Wipo publication date 30 June 2005

Acceptance publication date 27 May 2010

International Classifications

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4184 (2006.01)

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/058869 Priority application(s): WO2005/058869

27 May 2010 Application Accepted

  Published as AU-B-2004298457

23 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004298458-Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication

2004298456-Piperidine-amino-benzimidazole derivatives as inhibitors of respiratory syncytial virus replication